Stock Scorecard
Stock Summary for Instil Bio Inc (TIL) - $14.48 as of 5/3/2025 11:42:01 AM EST
Total Score
6 out of 30
Safety Score
41 out of 100
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for TIL
| Positive earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for TIL
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for TIL
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for TIL
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for TIL (41 out of 100)
| Stock Price Rating (Max of 10) | 5 |
| Historical Stock Price Rating (Max of 10) | 10 |
| Stock Price Trend (Max of 10) | 1 |
| Book Value (Max of 10) | 7 |
| Book Value to Price (Max of 10) | 8 |
| Analyst Buy Ratings (Max of 5) | 3 |
| Analyst Strong Buy Ratings (Max of 5) | 3 |
| Dividend Yield Percentage (Max of 10) | 0 |
| Operating Margin (Max of 10) | 0 |
| Trading Volume (Max of 10) | 4 |
| Price to Earnings (Max of 10) | 0 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | 0 |
Latest News for for TIL
Financial Details for TIL
Company Overview |
|
|---|---|
| Ticker | TIL |
| Company Name | Instil Bio Inc |
| Country | USA |
| Description | Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer patients. The company is headquartered in Dallas, Texas. |
| Sector Name | LIFE SCIENCES |
| Industry Name | BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) |
| Most Recent Quarter | 12/31/2024 |
| Next Earnings Date | 5/8/2025 |
Stock Price History |
|
| Last Day Price | 14.48 |
| Price 4 Years Ago | 342.20 |
| Last Day Price Updated | 5/3/2025 11:42:01 AM EST |
| Last Day Volume | 196,025 |
| Average Daily Volume | 144,051 |
| 52-Week High | 92.00 |
| 52-Week Low | 9.62 |
| Last Price to 52 Week Low | 50.52% |
Valuation Measures |
|
| Trailing PE | N/A |
| Industry PE | 42.07 |
| Sector PE | 37.03 |
| 5-Year Average PE | -43.01 |
| Free Cash Flow Ratio | 10.81 |
| Industry Free Cash Flow Ratio | 17.86 |
| Sector Free Cash Flow Ratio | 29.42 |
| Current Ratio Most Recent Quarter | 15.76 |
| Total Cash Per Share | 1.34 |
| Book Value Per Share Most Recent Quarter | 25.96 |
| Price to Book Ratio | 0.56 |
| Industry Price to Book Ratio | 9.82 |
| Sector Price to Book Ratio | 21.93 |
| Price to Sales Ratio Twelve Trailing Months | 55,329.79 |
| Industry Price to Sales Ratio Twelve Trailing Months | 48.24 |
| Sector Price to Sales Ratio Twelve Trailing Months | 28.34 |
| Analyst Buy Ratings | 2 |
| Analyst Strong Buy Ratings | 1 |
Share Statistics |
|
| Total Shares Outstanding | 6,558,900 |
| Market Capitalization | 94,972,872 |
| Institutional Ownership | N/A |
Dividends |
|
| Ex-Dividend Date | N/A |
| Previous Dividend Amount | 0.0000 |
| Current Dividend Amount | 0.0000 |
| Total Years Dividend Increasing | N/A |
| Trailing Annual Dividend Rate | 0.00 |
| Trailing Annual Dividend Yield | 0.00% |
| Forward Annual Dividend Rate | 0.00 |
| Forward Annual Dividend Yield | 0.00% |
| 5-Year Dividend Payments Count | 0 |
| 3-Year Average Dividend Yield | 0.00% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | 0.00% |
| 3-Year Dividend Growth Rate Percentage | 0.00% |
| 5-Year Dividend Growth Rate Percentage | 0.00% |
| All-Time Dividend Growth Rate Percentage | 0.00% |
| Dividend Payout Ratio | N/A |
Income Statement |
|
| Quarterly Earnings Growth YOY | 0.00% |
| Annual Earnings Growth | 52.50% |
| Reported EPS 12 Trailing Months | -11.39 |
| Reported EPS Past Year | 0.00 |
| Reported EPS Prior Year | -9.66 |
| Net Income Twelve Trailing Months | -74,135,000 |
| Net Income Past Year | -74,135,000 |
| Net Income Prior Year | -156,087,000 |
| Quarterly Revenue Growth YOY | 0.00% |
| 5-Year Revenue Growth | 0.00% |
| Operating Margin Twelve Trailing Months | 0.00% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 8,805,000 |
| Total Cash Past Year | 8,805,000 |
| Total Cash Prior Year | 9,195,000 |
| Net Cash Position Most Recent Quarter | -75,382,000 |
| Net Cash Position Past Year | -75,382,000 |
| Long Term Debt Past Year | 84,187,000 |
| Long Term Debt Prior Year | 81,427,000 |
| Total Debt Most Recent Quarter | 84,187,000 |
| Equity to Debt Ratio Past Year | 0.67 |
| Equity to Debt Ratio Most Recent Quarter | 0.67 |
| Total Stockholder Equity Past Year | 169,436,000 |
| Total Stockholder Equity Prior Year | 225,829,000 |
| Total Stockholder Equity Most Recent Quarter | 169,436,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | -55,696,000 |
| Free Cash Flow Per Share Twelve Trailing Months | -8.49 |
| Free Cash Flow Past Year | -65,696,000 |
| Free Cash Flow Prior Year | -102,692,000 |
Options |
|
| Put/Call Ratio | 0.00 |
| Has Options | False |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | -1.19 |
| MACD Signal | -0.84 |
| 20-Day Bollinger Lower Band | 12.99 |
| 20-Day Bollinger Middle Band | 19.02 |
| 20-Day Bollinger Upper Band | 25.05 |
| Beta | 1.76 |
| RSI | 41.47 |
| 50-Day SMA | 28.43 |
| 150-Day SMA | 97.49 |
| 200-Day SMA | 94.59 |
System |
|
| Modified | 5/3/2025 11:42:02 AM EST |